Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014 (2014), Article ID 690853, 6 pages
http://dx.doi.org/10.1155/2014/690853
Research Article

Serum Interleukin 17 Levels in Patients with Crohn’s Disease: Real Life Data

1Department of Gastroenterology, Elazig Education and Research Hospital, Rizaiye Mah. Inonu Caddesi, 23200 Elazig, Turkey
2Gastroenterology Department, Turkiye Gazetesi Hospital, 34381 Istanbul, Turkey
3Department of Gastroenterology, Ankara Oncology Education and Research Hospital, 06500 Ankara, Turkey
4Department of Gastroenterology, Batman State Hospital, 72070 Batman, Turkey
5Department of Genetics and Bioengineering, Yeditepe University, 34755 Istanbul, Turkey
6Department of Gastroenterology, Umraniye Training and Research Hospital, 34764 Istanbul, Turkey

Received 3 June 2014; Accepted 16 June 2014; Published 16 July 2014

Academic Editor: Giuseppe Murdaca

Copyright © 2014 Abdurrahman Sahin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Fiocchi, “Inflammatory bowel disease: etiology and pathogenesis,” Gastroenterology, vol. 115, no. 1, pp. 182–205, 1998. View at Publisher · View at Google Scholar · View at Scopus
  2. N. A. Braus and D. E. Elliott, “Advances in the pathogenesis and treatment of IBD,” Clinical Immunology, vol. 132, no. 1, pp. 1–9, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Brand, “Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease,” Gut, vol. 58, no. 8, pp. 1152–1167, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. L. A. Tesmer, S. K. Lundy, S. Sarkar, and D. A. Fox, “Th17 cells in human disease,” Immunological Reviews, vol. 223, no. 1, pp. 87–113, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. M. J. McGeachy, K. S. Bak-Jensen, Y. Chen et al., “TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain TH-17 cell-mediated pathology,” Nature Immunology, vol. 8, no. 12, pp. 1390–1397, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Oukka, “Th17 cells in immunity and autoimmunity,” Annals of the Rheumatic Diseases, vol. 67, no. supplement 3, pp. iii26–iii29, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Romagnani, “Human Th17 cells,” Arthritis Research and Therapy, vol. 10, no. 2, article 206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. R. M. Onishi and S. L. Gaffen, “Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease,” Immunology, vol. 129, no. 3, pp. 311–321, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Fujino, A. Andoh, S. Bamba et al., “Increased expression of interleukin 17 in inflammatory bowel disease,” Gut, vol. 52, no. 1, pp. 65–70, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Sarra, F. Pallone, T. T. MacDonald, and G. Monteleone, “IL-23/IL-17 axis in IBD,” Inflammatory Bowel Diseases, vol. 16, no. 10, pp. 1808–1813, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Olsen, R. Rismo, G. Cui, R. Goll, I. Christiansen, and J. Florholmen, “TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation,” Cytokine, vol. 56, no. 3, pp. 633–640, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. W. R. Best, J. M. Becktel, J. W. Singleton, and F. Kern Jr., “Development of a Crohn's disease activity index. National cooperative Crohn's disease study,” Gastroenterology, vol. 70, no. 3, pp. 439–444, 1976. View at Google Scholar · View at Scopus
  13. M. B. Frenz, P. Dunckley, L. Camporota, D. P. Jewell, and S. P. L. Travis, “Comparison between prospective and retrospective evaluation of Crohn's disease activity index,” American Journal of Gastroenterology, vol. 100, no. 5, pp. 1117–1120, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Veny, M. Esteller, E. Ricart, J. M. Pique, J. Panes, and A. Salas, “Late Crohn's disease patients present an increase in peripheral Th17 cells and cytokine production compared with early patients,” Alimentary Pharmacology and Therapeutics, vol. 31, no. 5, pp. 561–572, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Miletić, R. Stojanović, O. Pajić et al., “Serum interleukin-17 & nitric oxide levels in patients with primary Sjögren's syndrome,” Indian Journal of Medical Research, vol. 135, no. 4, pp. 513–519, 2012. View at Google Scholar · View at Scopus
  16. L. Zhao, Y. Tang, Z. You et al., “Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression,” PLoS ONE, vol. 6, no. 4, Article ID e18909, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Yue, X. You, L. Zhao et al., “The effects of adalimumab and methotrexate treatment on peripheral Th17 cells and IL-17/IL-6 secretion in rheumatoid arthritis patients,” Rheumatology International, vol. 30, no. 12, pp. 1553–1557, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Y. Chen, Y. M. Chen, H. H. Chen, C. W. Hsieh, C. C. Lin, and J. L. Lan, “Increasing levels of circulating Th17 cells and interleukin-17 in rheumatoid arthritis patients with an inadequate response to anti-TNF-α therapy,” Arthritis Research and Therapy, vol. 13, no. 4, article R126, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. C. W. Lees, J. C. Barrett, M. Parkes, and J. Satsangi, “New IBD genetics: common pathways with other diseases,” Gut, vol. 60, no. 12, pp. 1739–1753, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. T. S. Stappenbeck, J. D. Rioux, A. Mizoguchi et al., “Crohn disease: a current perspective on genetics, autophagy and immunity,” Autophagy, vol. 7, no. 4, pp. 355–374, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. F. Caprioli, F. Bosè, R. L. Rossi et al., “Reduction of CD68+ macrophages and decreased il-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy,” Inflammatory Bowel Diseases, vol. 19, no. 4, pp. 729–739, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Holtta, P. Klemetti, H. M. Salo et al., “Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis,” Journal of Pediatric Gastroenterology and Nutrition, vol. 57, pp. 287–292, 2013. View at Google Scholar
  23. T. Kobayashi, S. Okamoto, T. Hisamatsu et al., “IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease,” Gut, vol. 57, no. 12, pp. 1682–1689, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. E. Franzè, R. Caruso, C. Stolfi et al., “Lesional accumulation of CD163-expressing cells in the gut of patients with inflammatory bowel disease,” PLoS ONE, vol. 8, no. 7, Article ID e69839, 2013. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Mohammadi, M. J. Zahedi, A. R. Nikpoor, M. R. Baneshi, and M. M. Hayatbakhsh, “Interleukin-17 serum levels and TLR4 polymorphisms in Ulcerative Colitis,” Iranian Journal of Immunology, vol. 10, no. 2, pp. 83–92, 2013. View at Google Scholar · View at Scopus
  26. D. Schwarzmaier, D. Foell, T. Weinhage, G. Varga, and J. Däbritz, “Peripheral monocyte functions and activation in patients with quiescent Crohn's disease,” PLoS ONE, vol. 8, no. 4, Article ID e62761, 2013. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Ueno, H. Jijon, R. Chan et al., “Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients,” Inflammatory Bowel Diseases, vol. 19, no. 2, pp. 2522–2534, 2013. View at Publisher · View at Google Scholar
  28. R. Pappu, V. Ramirez-Carrozzi, N. Ota, W. Ouyang, and Y. Hu, “The IL-17 family cytokines in immunity and disease,” Journal of Clinical Immunology, vol. 30, no. 2, pp. 185–195, 2010. View at Publisher · View at Google Scholar · View at Scopus